Biogen (NASDAQ:BIIB) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Biogen missed estimated earnings by 17.35%, reporting an EPS of $3.62 versus an estimate of $4.38.
Revenue was down $162.00 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 0.62% increase in the share price the next day.
Here’s a look at Biogen’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 3.40 | 4.11 | 4.55 | 5.04 |
| EPS Actual | 3.39 | 4.77 | 5.68 | 5.34 |
| Revenue Estimate | 2.62B | 2.67B | 2.61B | 2.65B |
| Revenue Actual | 2.73B | 2.78B | 2.77B | 2.69B |
To track all earnings releases for Biogen visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
